Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population has been poorly quantified. The aim of this study was to measure the risk of asthma exacerbations with beta-blockers prescribed to a general population with asthma and CVD. Methods: Linked data from the UK Clinical Practice Research Datalink was used to perform nested case-control studies among people with asthma and CVD matched on age, gender and calendar time. Adjusted incidence rate ratios (IRR) were calculated for the association between o...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Background: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medic...
Background beta-Antagonists have recently been proposed for the treatment of chronic asthma; however...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Abstract Background Cardiovasc...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Background: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medic...
Background beta-Antagonists have recently been proposed for the treatment of chronic asthma; however...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Background: Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, saf...
Abstract Background Cardiovasc...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Background: Globally, cardiovascular disease (CVD) is the leading cause of death. Beta-blocker medic...
Background beta-Antagonists have recently been proposed for the treatment of chronic asthma; however...